american society of hematology (ASH)

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1771507439940
Cache Key: cqdTagPageBySlug:american-society-of-hematology-ash
fetchCache[cqdTagPageBySlug:american-society-of-hematology-ash].expirationTime: falsey
fetchCache[cqdTagPageBySlug:american-society-of-hematology-ash]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: -615413
-- Key: cqdTagPageBySlug:medical-school, seconds remaining: -615413
-- Key: cqdPostsByTag:cqd-migrated-tag-2347,1,10, seconds remaining: -615333
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:american-society-of-hematology-ash - retrieving from Sanity
CCCache.dataFetchCount: 823
Cache cleanup seconds remaining: 30000

Tag: american society of hematology (ASH)

Looking Forward: Advances and Obstacles in Blood Cancer Treatment

Updated Guidelines for Immune Thrombocytopenic Purpura Focus on Treating Patients Without Bleeding

New Drug Combination Can Extend the Lives of Older Patients with Ph+ Acute Lymphoblastic Leukemia

Addition of CAEL-101 to Anti-Plasma Cell Dyscrasia Therapy May Have Long-Term Benefits in Patients with AL Amyloidosis

Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma

Modified Drug Regimen May Reduce Risks in Allogeneic Hematopoietic Cell Transplant Patients